Imagen de Portada

Hippocampal Subfield Volume in Relation to Cerebrospinal Fluid Amyloid‐ß in Early Alzheimer's Disease: Diagnostic Utility of 7T MRI

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Oluwatobi F. Adeyemi, Penny Gowland, Richard Bowtell, Olivier Mougin, Akram A. Hosseini
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	European Journal of Neurology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hippocampal Subfield Volumes, Depression and Cognitive Decline in Alzheimer's Disease: A Longitudinal 7T Study
por: Beili Shao, et al.
Publicado: (2025)

Lecanemab‐Associated Amyloid‐β Protofibril in Cerebrospinal Fluid Correlates with Biomarkers of Neurodegeneration in Alzheimer's Disease
por: Moeko Noguchi‐Shinohara, et al.
Publicado: (2025)

Hippocampal Subfields Volume: Another Hint of the Continuum Between CAA and AD ?
por: Benedetta Storti, et al.
Publicado: (2025)

Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy
por: Philipp Arndt, et al.
Publicado: (2026)

Associations of Cerebrospinal Fluid Orexin‐A, Alzheimer Disease Biomarkers, and Cognitive Performance
por: Ruijin Lu, et al.
Publicado: (2025)

Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights
por: Georgios Mangioris, et al.
Publicado: (2024)

Heparin‐Binding Protein in Cerebrospinal Fluid as a Biomarker for Bacterial Meningitis: A Study of Diagnostic Accuracy
por: Sabine E. Olie, et al.
Publicado: (2025)

Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
por: Ryosuke Shimasaki, et al.
Publicado: (2025)

Amyloid PET in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts
por: Julien Lagarde, et al.
Publicado: (2025)

Diagnostic and Prognostic Value of Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta‐Analysis
por: Kazuki Obara, et al.
Publicado: (2025)

Increased Extra‐Axial Cerebrospinal Fluid Volume in Children With Angelman Syndrome: Links to Sleep Problems and Seizures
por: Zumin Chen, et al.
Publicado: (2025)

Utility, Costs and Cost‐Utility of Amyloid‐PET in the Diagnostic Process of Memory Clinic Patients: A Trial‐Based Economic Evaluation From AMYPAD‐DPMS
por: Ingrid S. van Maurik, et al.
Publicado: (2025)

Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers
por: Christopher A. Brown, et al.
Publicado: (2026)

Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks
por: Marta Milà‐Alomà, et al.
Publicado: (2025)

Cerebral Amyloid Angiopathy‐Related Inflammation Spectrum Disorders: Introduction of a Novel Concept and Diagnostic Criteria
por: Andreas Charidimou
Publicado: (2024)

Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension
por: Adrian Scutelnic, et al.
Publicado: (2025)

Diagnostic and Prognostic Utility of Plasma p‐tau217 for Alzheimer's Disease in Chinese Elderly: Insights From the SILCODE Study With a Derived Threshold
por: Ruixian Li, et al.
Publicado: (2026)

Cerebral Amyloid Angiopathy‐Related Inflammation in Iatrogenic Cerebral Amyloid Angiopathy
por: Larysa Panteleienko, et al.
Publicado: (2025)

Letter to the Editor: “Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension”
por: Yixin Fu, et al.
Publicado: (2025)

Letter to the Editor: Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension
por: Hafiza Aimal Nizami, et al.
Publicado: (2025)

Long‐Term Effects of Severe COVID‐19 on the Hippocampus: A 7T MRI Comparison with Alzheimer’s Disease
por: Beili Shao, et al.
Publicado: (2025)

A Case of Acute‐Onset CIDP With Pleocytosis in Cerebrospinal Fluid Presenting With Recurrent Acute Limb Weakness
por: Masahiro Ishida, et al.
Publicado: (2025)

Response to Letter to the Editor: Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension
por: Adrian Scutelnic, et al.
Publicado: (2025)

Response to Letter to Editor: Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension
por: Adrian Scutelnic, et al.
Publicado: (2026)

Factors Affecting Resilience and Prevention of Alzheimer's Disease and Related Dementias
por: Arjun V. Masurkar, et al.
Publicado: (2024)

Comment on: A Case of Acute‐Onset CIDP With Pleocytosis in Cerebrospinal Fluid Presenting With Recurrent Acute Limb Weakness
por: Akshay Kumar, et al.
Publicado: (2025)

Clinical–Radiological Spectrum of Cerebral Amyloid Angiopathy‐Related Inflammation
por: Larysa Panteleienko, et al.
Publicado: (2025)

The Utility of Olfactory Testing to Discriminate Parkinson's Disease From Diagnostic Mimics: A Systematic Review and Meta‐Analysis
por: Christoph Theyer, et al.
Publicado: (2025)

Increased Cerebrospinal Fluid Adenosine 5′‐Triphosphate Levels in Patients with Guillain–Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
por: Takamasa Nukui, et al.
Publicado: (2024)

Inflammation in Cerebral Amyloid Angiopathy‐Related Transient Focal Neurological Episodes
por: Amina Sellimi, et al.
Publicado: (2025)

Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers
por: Elizabeth R. Dellar, et al.
Publicado: (2024)

Faster Decay of Cerebrospinal Fluid Red Blood Cells and Total Protein Predict Good Functional Outcome After Subarachnoid Hemorrhage
por: Anna Berek, et al.
Publicado: (2025)

Clarifying the Moderating Role of Socioeconomic Status on Amyloid‐Related Gray Matter Atrophy
por: Yun‐Xiang Zhou, et al.
Publicado: (2025)

Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease
por: Sofie Slingerland, et al.
Publicado: (2025)

Reply to “Clarifying the Moderating Role of Socioeconomic Status on Amyloid‐Related Gray Matter Atrophy”
por: Dario Bachmann, et al.
Publicado: (2025)

Evaluating the Effect of Alzheimer's Disease‐Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy
por: Indira Garcia‐Cordero, et al.
Publicado: (2024)

Cerebral Amyloid Angiopathy‐Related Inflammation With Abnormal Higher‐Order Visual Dysfunctions
por: Fabian H. Rossi, et al.
Publicado: (2025)

Cerebrospinal Fluid Research
Publicado: (2012)

Increased Cortical Thickness in Alzheimer's Disease
por: Tony X. Phan, et al.
Publicado: (2024)

CSF Biomarker Profile of Cerebral Amyloid Angiopathy: Diagnostic Performance and Imaging Correlates in a Hospital‐Based Neurology Cohort
por: Aida Fernández‐Lebrero, et al.
Publicado: (2026)